by Boehringer Ingelheim
Romifidine hydrochloride 1% injection. Approximately 5 doses in a 20 ml vial. Dose is 1/2 to 1 ml per 200 lbs.
Sedivet 1.0% Injection is an α2-adrenoceptor agonist with sedative and analgesic properties.
Dosage & Administration
Sedation and Analgesia: Administer slowly as a single IV injection
using a dosage range of 40-120 µg/kg (0.4 1.2 mL/100 kg body weight)
depending on the depth and duration of sedation that is required.
Preanesthesia: A single IV injection using a dose of 100 µg/kg (1.0
mL/100 kg body weight) was shown to be effective in the preanesthesia
dose confirmation study. See product insert for complete information.
Use of Sedivet 1.0% Injection with other α2-agonists is not
recommended since the effects could be additive. Adverse effects may be
potentiated by the administration of other sedatives, tranquilizers, or
opiods. Use of epinephrine should be avoided. Anesthetic doses should be
reduced in the presence of Sedivet 1.0% Injection to avoid excessive
depression of the central nervous system. Should not be used in horses
with respiratory disease, hepatic or renal disease, dehydration, or
other systemic conditions of compromised health. Effects have not been
evaluated in horses with colic, compromised cardiovascular function,
pregnant mares, foals or in horses intended for breeding. See product
insert for complete information.
Sedative and analgesic to facilitate handling, clinical
examinations, clinical procedures, and minor surgical procedures in
adult horses. Also indicated as a preanesthetic prior to the induction
of general anesthesia in adult horses.